Xirmooyinka baaritaanka degdega ah ee antigen-ka COVID-19 ee iskiis AMRDT109 Plus

Isticmaalka la damacsan yahay
Waxaa loo adeegsaday go'aaminta tayada IgG iyo IgM unugyada difaaca jirka ee novel coronavirus ee serum bini'aadamka, balaasmaha ama dhiiga oo dhan in vitro.

Xirmooyinka baaritaanka degdega ah ee antigen-ka COVID-19 ee AMRDT109 Plus Features
Tijaabada degdega ah: Kaliya 15 daqiiqo
Qalliin ku habboon oo aan loo baahnayn falanqeeye
Baaritaanka hore iyo ka saarida kiisaska shakiga leh
Yaree heerka ogaanshaha khaldan ee baaritaanka nucleic acid

Xirmooyinka baaritaanka degdega ah ee antigen-ka COVID-19 ee AMRDT109 Plus Waaxda khuseysa
• Waaxda Gurmadka
• ICU

• Waaxda Pneumology
• Qaybta Hawlaha Wadnaha-Sababada

Codsiga Caafimaad
Caddaynta hadda jirta waxay soo jeedinaysaa in novel coronavirus lagu kala qaado inta badan dhibcaha dhibcaha, hawada hawada, iyo taabashada tooska ah ee dheecaanka.
• Bini'aadamka uu ku dhacay novel coronavirus (2019-ncov), habka difaaca jidhku waxa uu soo saaraa jawaab celin difaac oo fayraska ah, isaga oo soo saara unugyo gaar ah.Go'aaminta unugyada difaaca ee khuseeya waxaa loo isticmaali karaa in lagu baaro caabuqa coronaviruses-ka cusub.

Xirmo
25 Tijaabada/Sanduuqa

2019-nCov IgG/IgM Qalabka Tijaabada Degdega ah ee Kahortagga Jirka ee AMRDT109 Plus
Waxa loo isticmaalaa in lagu ogaado tayada coronavirus-ka cusub (SARS-CcV-2) antigen-ka ee muunadaha suufka sanka ee bini'aadamka ee vitro.
Coronavirus waa qoys weyn oo si weyn ugu dhex jira dabeecadda.Waxay u nugul tahay dadka iyo xayawaan badan.Waxaa loogu magac daray fibroids-ka corona-sida oogada sare ee qaybaha fayraska.Astaamaha caafimaad ee caadiga ah ee caabuqa cusub ee coronavirus (2019-nCoV) waa qandho, daal, murqo xanuun, iyo qufac qalalan, kaas oo u gudbi kara oof wareen daran, neef-mareenka oo shaqayn waayay, iyo xitaa nafta halis gelisa.

Go'aaminta antigen-ka coronavirus waxaa loo isticmaali karaa in lagu caawiyo baaritaanka hore ee caabuqa coronavirus.Qalabkani wuxuu xukumi karaa caabuqa coronavirus, laakiin ma kala saaro SARS-CoV ama caabuqa SARS-CoV-2.